Shereen Ezzat

23.9k total citations · 4 hit papers
317 papers, 16.4k citations indexed

About

Shereen Ezzat is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Shereen Ezzat has authored 317 papers receiving a total of 16.4k indexed citations (citations by other indexed papers that have themselves been cited), including 215 papers in Endocrinology, Diabetes and Metabolism, 73 papers in Surgery and 71 papers in Molecular Biology. Recurrent topics in Shereen Ezzat's work include Pituitary Gland Disorders and Treatments (138 papers), Growth Hormone and Insulin-like Growth Factors (82 papers) and Thyroid Cancer Diagnosis and Treatment (56 papers). Shereen Ezzat is often cited by papers focused on Pituitary Gland Disorders and Treatments (138 papers), Growth Hormone and Insulin-like Growth Factors (82 papers) and Thyroid Cancer Diagnosis and Treatment (56 papers). Shereen Ezzat collaborates with scholars based in Canada, United States and United Kingdom. Shereen Ezzat's co-authors include L. Sylvia, Tetsuo Kondo, Jeremy L. Freeman, Özgür Mete, Harley S. Smyth, Linda J. Woodhouse, Mary Lee Vance, Carol C. Cheung, Irving B. Rosen and Anna M. Sawka and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Shereen Ezzat

312 papers receiving 16.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The prevalence of pituitary adenomas

2004 925 citations Shereen Ezzat, L. Sylvia et al. profile →
Pathogenetic mechanisms in thyroid follicular-cell neoplasia

2006 708 citations Tetsuo Kondo, Shereen Ezzat et al. profile →
Thyroid incidentalomas. Prevalence by palpation and ultrasonography

1994 538 citations Shereen Ezzat profile →
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

2022 486 citations Özgür Mete, Shereen Ezzat et al. Endocrine Pathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shereen Ezzat Canada	67	11.1k	4.4k	4.2k	3.1k	2.5k	317	16.4k
John Wass United Kingdom	78	14.4k 1.3×	6.2k 1.4×	3.3k 0.8×	3.5k 1.1×	1.2k 0.5×	358	20.9k
Philippe Chanson France	72	11.9k 1.1×	5.3k 1.2×	2.7k 0.6×	2.6k 0.9×	884 0.4×	396	16.7k
Robert F. Gagel United States	58	7.1k 0.6×	3.9k 0.9×	3.6k 0.8×	3.2k 1.0×	4.7k 1.9×	221	14.7k
Electron Kebebew United States	69	9.8k 0.9×	7.7k 1.7×	3.8k 0.9×	3.3k 1.1×	4.3k 1.7×	378	19.1k
Bruce G. Robinson Australia	56	5.0k 0.5×	3.0k 0.7×	3.4k 0.8×	1.6k 0.5×	2.2k 0.9×	227	11.3k
Kálmán Kovács Canada	74	15.5k 1.4×	5.9k 1.3×	3.4k 0.8×	4.6k 1.5×	1.2k 0.5×	595	20.4k
Mauro Papotti Italy	66	5.7k 0.5×	4.0k 0.9×	2.5k 0.6×	5.5k 1.8×	5.8k 2.3×	382	17.1k
Albert Beckers Belgium	54	7.5k 0.7×	3.9k 0.9×	1.5k 0.3×	2.9k 0.9×	951 0.4×	335	10.5k
Stephen M. Shalet United Kingdom	66	8.2k 0.7×	1.7k 0.4×	3.0k 0.7×	844 0.3×	1.6k 0.6×	268	13.7k
Catharina Larsson Sweden	62	3.1k 0.3×	2.1k 0.5×	6.1k 1.4×	3.1k 1.0×	4.2k 1.7×	358	14.4k

Countries citing papers authored by Shereen Ezzat

Since Specialization

Citations

This map shows the geographic impact of Shereen Ezzat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shereen Ezzat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shereen Ezzat more than expected).

Fields of papers citing papers by Shereen Ezzat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shereen Ezzat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shereen Ezzat. The network helps show where Shereen Ezzat may publish in the future.

Co-authorship network of co-authors of Shereen Ezzat

This figure shows the co-authorship network connecting the top 25 collaborators of Shereen Ezzat. A scholar is included among the top collaborators of Shereen Ezzat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shereen Ezzat. Shereen Ezzat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Akirov, Amit, et al.. (2019). Treatment Options for Pancreatic Neuroendocrine Tumors. Cancers. 11(6). 828–828. 53 indexed citations

Saeed, Omar, Lori J. Bernstein, Rouhi Fazelzad, et al.. (2019). Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis. Journal of Cancer Survivorship. 13(2). 231–243. 14 indexed citations

Gomez-Hernandez, Karen, Shereen Ezzat, L. Sylvia, & Özgür Mete. (2015). Clinical implications of accurate subtyping of pituitary adenomas: perspectives from the treating physician. Turkish Journal of Pathology. 31 Suppl 1. 4–17. 30 indexed citations

Tateno, Toru, Lei Zheng, Katsuhiko Yoshimoto, et al.. (2014). FGFR4 Polymorphic Variants Modulate Phenotypic Features of Cushing Disease. Molecular Endocrinology. 28(4). 525–533. 14 indexed citations

Sylvia, L. & Shereen Ezzat. (2013). Genomic Approaches to Problems in Pituitary Neoplasia. Endocrine Pathology. 25(3). 209–213. 10 indexed citations

Guo, Miao, Wei Liu, Stefano Serra, L. Sylvia, & Shereen Ezzat. (2012). FGFR2 Isoforms Support Epithelial–Stromal Interactions in Thyroid Cancer Progression. Cancer Research. 72(8). 2017–2027. 22 indexed citations

Serra, Stefano, Lei Zheng, Manal M. Hassan, et al.. (2012). The FGFR4-G388R Single-Nucleotide Polymorphism Alters Pancreatic Neuroendocrine Tumor Progression and Response to mTOR Inhibition Therapy. Cancer Research. 72(22). 5683–5691. 40 indexed citations

Ezzat, Shereen, et al.. (2012). Adjuvant Growth Hormone for Ovulation Induction with Gonadotropins in the Treatment of a Woman with Hypopituitarism. SHILAP Revista de lepidopterología. 2012. 1–3. 8 indexed citations

Vallette, Sophie, Shereen Ezzat, Constance L. Chik, et al.. (2012). Emerging trends in the diagnosis and treatment of acromegaly in Canada. Clinical Endocrinology. 79(1). 79–85. 36 indexed citations

10.

Sawka, Anna M., Irada Ibrahim-zada, Richard Tsang, et al.. (2010). Dietary Iodine Restriction in Preparation for Radioactive Iodine Treatment or Scanning in Well-Differentiated Thyroid Cancer: A Systematic Review. Thyroid. 20(10). 1129–1138. 63 indexed citations

11.

Simpson, Craig D., Imtiaz A. Mawji, Kika Anyiwe, et al.. (2009). Inhibition of the Sodium Potassium Adenosine Triphosphatase Pump Sensitizes Cancer Cells to Anoikis and Prevents Distant Tumor Formation. Cancer Research. 69(7). 2739–2747. 84 indexed citations

12.

Sylvia, L., et al.. (2008). Ikaros Modulates Cholesterol Uptake: A Link between Tumor Suppression and Differentiation. Cancer Research. 68(10). 3715–3723. 20 indexed citations

13.

Liu, Wei, Sonia Cheng, L. Sylvia, & Shereen Ezzat. (2008). The Melanoma-Associated Antigen A3 Mediates Fibronectin-Controlled Cancer Progression and Metastasis. Cancer Research. 68(19). 8104–8112. 113 indexed citations

14.

Kondo, Tetsuo, L. Sylvia, & Shereen Ezzat. (2008). Epigenetic Dysregulation in Thyroid Neoplasia. Endocrinology and Metabolism Clinics of North America. 37(2). 389–400. 25 indexed citations

15.

Sylvia, L., Jing Jiang, Kimberly Loesch, et al.. (2007). A Growth Hormone Receptor Mutation Impairs Growth Hormone Autofeedback Signaling in Pituitary Tumors. Cancer Research. 67(15). 7505–7511. 49 indexed citations

16.

Kondo, Tetsuo, Lei Zheng, Wei Liu, et al.. (2007). Epigenetically Controlled Fibroblast Growth Factor Receptor 2 Signaling Imposes on the RAS/BRAF/Mitogen-Activated Protein Kinase Pathway to Modulate Thyroid Cancer Progression. Cancer Research. 67(11). 5461–5470. 54 indexed citations

17.

Rucker, Diana, Shereen Ezzat, Anastasia Diamandi, Javad Khosravi, & David A. Hanley. (2004). IGF‐I and testosterone levels as predictors of bone mineral density in healthy, community‐dwelling men. Clinical Endocrinology. 60(4). 491–499. 40 indexed citations

18.

Ezzat, Shereen, Lei Zheng, Harley S. Smyth, & L. Sylvia. (1997). The c‐erbB‐2/neu proto‐oncogene in human pituitary tumours. Clinical Endocrinology. 46(5). 599–606. 31 indexed citations

19.

Ezzat, Shereen, et al.. (1996). Prevalence of Activating ras Mutations in Morphologically Characterized Thyroid Nodules. Thyroid. 6(5). 409–416. 79 indexed citations

20.

Ezzat, Shereen, et al.. (1994). [13C]NMR studies of the effect of the somatostatin analogue octreotide on hepatic glycogenesis and glycogenolysis. Peptides. 15(7). 1223–1227. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact